Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 96.63 Million USD | 29.09% |
| 2022 | 74.85 Million USD | 36.31% |
| 2021 | 54.91 Million USD | 29.39% |
| 2020 | 42.44 Million USD | 0.49% |
| 2019 | 42.23 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 23.16 Million USD | 26.23% |
| 2024 Q1 | 18.35 Million USD | -30.72% |
| 2023 Q4 | 26.48 Million USD | 5.04% |
| 2023 FY | 96.63 Million USD | 29.09% |
| 2023 Q3 | 25.21 Million USD | 7.2% |
| 2023 Q2 | 23.52 Million USD | 9.86% |
| 2023 Q1 | 21.41 Million USD | 0.9% |
| 2022 Q2 | 17.89 Million USD | 5.92% |
| 2022 Q1 | 16.89 Million USD | 4.56% |
| 2022 FY | 74.85 Million USD | 36.31% |
| 2022 Q4 | 21.21 Million USD | 12.56% |
| 2022 Q3 | 18.85 Million USD | 5.35% |
| 2021 Q1 | 12.21 Million USD | -5.39% |
| 2021 FY | 54.91 Million USD | 29.39% |
| 2021 Q4 | 16.15 Million USD | 19.9% |
| 2021 Q3 | 13.47 Million USD | 3.1% |
| 2021 Q2 | 13.07 Million USD | 7.03% |
| 2020 FY | 42.44 Million USD | 0.49% |
| 2020 Q4 | 12.9 Million USD | 29.68% |
| 2020 Q3 | 9.95 Million USD | 16.29% |
| 2020 Q2 | 8.56 Million USD | -22.33% |
| 2020 Q1 | 11.02 Million USD | 0.0% |
| 2019 FY | 42.23 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AngioDynamics, Inc. | 303.91 Million USD | 68.204% |
| AtriCure, Inc. | 399.24 Million USD | 75.796% |
| Avinger, Inc. | 7.65 Million USD | -1162.846% |
| Azenta, Inc. | 665.07 Million USD | 85.47% |
| BioLife Solutions, Inc. | 143.27 Million USD | 32.552% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 97.311% |
| Daxor Corporation | 1.28 Million USD | -7446.417% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -428.656% |
| Femasys Inc. | 1.07 Million USD | -8914.525% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 13.913% |
| Hologic, Inc. | 4.03 Billion USD | 97.602% |
| ICU Medical, Inc. | 2.25 Billion USD | 95.723% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 98.644% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -238.853% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 50.056% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -8284.795% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -8284.795% |
| Masimo Corporation | 2.04 Billion USD | 95.282% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 0.48% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 92.315% |
| Nephros, Inc. | 14.23 Million USD | -578.698% |
| NovoCure Limited | 509.33 Million USD | 81.028% |
| NEXGEL, Inc. | 4.08 Million USD | -2263.243% |
| NEXGEL, Inc. | 4.08 Million USD | -2263.243% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -3219.581% |
| OraSure Technologies, Inc. | 405.47 Million USD | 76.168% |
| Pro-Dex, Inc. | 53.84 Million USD | -79.468% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -5328.537% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -405.817% |
| QuidelOrtho Corporation | 2.99 Billion USD | 96.777% |
| Repligen Corporation | 638.76 Million USD | 84.872% |
| Sanara MedTech Inc. | 64.98 Million USD | -48.689% |
| STAAR Surgical Company | 322.41 Million USD | 70.028% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -92.404% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 97.563% |
| Jin Medical International Ltd. | 19.82 Million USD | -387.517% |